D. Paul Harkin

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome

Kim E. Nichols, D. Paul Harkin, Seth Levitz et al. · Proceedings of the National Academy of Sciences · 1998 · 495 citations · Full text

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.

Jennifer E. Quinn, Richard D. Kennedy, Paul B. Mullan et al. · PubMed · 2003 · 402 citations

Tumor Biology, Brca1 Functions, Medicine +13

Heterozygous ATM mutations do not contribute to early onset of breast cancer

Michael G. FitzGerald, James Bean, Sanjay R. Hegde et al. · Nature Genetics · 1997 · 343 citations

Breast Oncology, Somatic Variant, Tumor Heterogeneity +10

BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy

Jennifer E. Quinn, Colin R. James, Gail E. Stewart et al. · Clinical Cancer Research · 2007 · 208 citations

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.

Michael G. FitzGerald, D. Paul Harkin, Sandra Silva-Arrieta et al. · Proceedings of the National Academy of Sciences · 1996 · 201 citations · Full text

Germ-line Mutations, Cancer Pathology, Genetics +18